Characteristics of Asthma Exacerbations in Emergency Care in Switzerland—Demographics, Treatment, and Burden of Disease in Patients with Asthma Exacerbations Presenting to an Emergency Department in Switzerland (CARE-S)

Author:

Rueegg Marco1ORCID,Busch Jeannette-Marie2,van Iperen Peter3,Leuppi Joerg D.24ORCID,Bingisser Roland14ORCID

Affiliation:

1. Emergency Department, University Hospital Basel, 4031 Basel, Switzerland

2. University Center of Internal Medicine, Cantonal Hospital Baselland, 4410 Liestal, Switzerland

3. Department of Respiratory and Immunology Biologics, AstraZeneca AG, 6340 Baar, Switzerland

4. Medical Faculty, University of Basel, 4056 Basel, Switzerland

Abstract

Emergency care for asthma is provided by general practitioners, pulmonologists, and emergency departments (EDs). Although it is known that patients presenting to EDs with acute asthma exacerbations are a vulnerable population and that this mode of presentation is a risk marker for more severe complications, research on this population is scarce. We conducted a retrospective study on patients with asthma exacerbations who presented to the ED of the University Hospital Basel, Switzerland, during 2017–2020. Of the last 200 presentations, 100 were selected and analyzed to assess demographic information, the use of previous and ED-prescribed asthma medication, and clinical outcomes after a mean period of time of 18 months. Of these 100 asthma patients, 96 were self-presenters, and 43 had the second highest degree of acuity (emergency severity index 2). Global Initiative for Asthma (GINA) step 1 and step 3 were the most common among patients with known GINA levels, accounting for 22 and 18 patients, respectively. A total of 4 patients were undergoing treatment with oral corticosteroids at presentation, and 34 were at discharge. At presentation, 38 patients used the combination therapy of inhaled corticosteroid/long-acting β2-agonist (ICS/LABA), and 6 patients underwent ICS monotherapy. At discharge, 68 patients were prescribed with ICS/LABA. At entry to the ED, about one-third of patients did not use any asthma medication. In total, 10 patients were hospitalized. None of them needed invasive or non-invasive ventilation. A follow-up for the study was precluded by the majority of patients. This group of asthma patients seemed particularly vulnerable as their asthma medication at presentation was often not according to guidelines or even lacking, and almost all the patients had self-presented to the ED without any reference from a physician. The majority of patients did not give consent to the collection of any follow-up information. These medical shortcomings reflect an urgent medical need to improve care for patients at high risk of asthma exacerbations.

Funder

AstraZeneca AG

Publisher

MDPI AG

Subject

General Medicine

Reference33 articles.

1. Global Initiative for Asthma (2022, October 01). Asthma Management and Prevention. Pocket Guide for Health Professionals. Available online: www.ginasthma.org.

2. Global Initiative for Asthma (2022, October 01). Global Strategy for Asthma Management and Prevention. Available online: https://ginasthma.org/wp-content/uploads/2021/05/Whats-new-in-GINA-2021_final_V2.pdf.

3. Combination fixed-dose β agonist and steroid inhaler as required for adults or children with mild asthma: A Cochrane systematic review;Crossingham;BMJ Evid. Based Med.,2022

4. Royal College of Emergency Medicine (2022, October 01). Moderate and Acute Asthma. Clinical Audit 2016/17. Available online: https://rcem.ac.uk/wp-content/uploads/2021/11/Moderate_and_Acute_Severe_Asthma_Clinical_Audit_2016_17.pdf.

5. (2017). Emergency departments are struggling to meet asthma care standards, audit shows. BMJ, 357, j2618.

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3